Clinical trial
Study Of Atopic Dermatitis In Pediatrics
NCT00257569 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00257569 |
|---|---|
| Title | Study Of Atopic Dermatitis In Pediatrics |
| Official title | Evaluation of the Efficacy and Safety of Cetirizine Dry Syrup in Children -Suffering From Atopic Dermatitis- |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dermatitis, Atopic |
| Intervention type | Drug |
| Interventions | Cetirizine Dry Syrup |
| Enrollment | 278 |
| Start date | Aug 1, 2005 |
| First posted | Nov 23, 2005 |
| Last update posted | May 6, 2013 |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: